Leukemia accounts for 10.6% share of global Oncology clinical trial activity in 2020
Leukemia accounted for a 10.6% share of the global clinical trials within the Oncology therapy area in 2020, registering a…
Leukemia accounted for a 10.6% share of the global clinical trials within the Oncology therapy area in 2020, registering a…
Psoriasis accounted for a 17.5% share of the global clinical trials within the Immunology therapy area in 2020, registering an…
The global clinical trials activity saw an increase of 5.9% in Q2 2021, when compared with the rolling average of…
Stroke accounted for a 12.6% share of the global clinical trials within the Cardiovascular therapy area in 2020, registering an…
Rheumatoid Arthritis accounted for an 18.9% share of the global clinical trials within the Immunology therapy area in 2020, registering…
Osteoarthritis accounted for a 26.2% share of the global clinical trials within the Musculoskeletal Disorders therapy area in 2020, registering…
Hepatitis C accounted for a 0.9% share of the global clinical trials within the Infectious Disease therapy area in 2020,…
Asthma accounted for a 13.4% share of the global clinical trials within the Respiratory therapy area in 2020, registering a…
Thank you for subscribing to Pharmaceutical Technology